ADCIRCA

Medicinal product

(Invented) name

ADCIRCA

Active substance (s)

Tadalafilis

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BE08, Tadalafil

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2008-10-01

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Tadalafilis	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
42764	56532	1056532	lizdinė plokštelė	N28		Receptinis	EU/1/08/476/005	Netiekiama	-	-	No	-	-
42765	56533	1056533	lizdinė plokštelė	N56		Receptinis	EU/1/08/476/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2008-10-01	Registruotas